本頁面由Tiger Trade Technology Pte. Ltd.提供服務

德康醫療

86.45
+1.772.09%
盤後86.450.00000.00%17:34 EDT
成交量:596.09萬
成交額:5.14億
市值:326.23億
市盈率:34.08
高:87.36
開:84.04
低:83.26
收:84.68
52周最高:92.59
52周最低:54.11
股本:3.77億
流通股本:3.76億
量比:1.42
換手率:1.59%
股息:- -
股息率:- -
每股收益(TTM):2.54
每股收益(LYR):2.09
淨資產收益率:38.49%
總資產收益率:10.33%
市淨率:12.44
市盈率(LYR):41.37

資料載入中...

2024/09/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/25

重要事件披露

Form 8-K - Current report
2024/07/25

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/25

重要事件披露

Form 8-K - Current report
2024/04/25

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities